News

HSCT shows promising results as a cure for very early-onset inflammatory bowel disease caused by IL-10 receptor deficiency.

Recent studies have identified a gene signature known as the senescent hepatocyte gene signature that tracks with MASLD progression.

Explore EBMT 2025 results on transplantation outcomes for Myelodysplastic Syndrome and Acute Myeloid Leukaemia, highlighting survival and relapse data.

Adoptive cell therapy with memory T lymphocytes clears infections in patients that are immunocompromised, showing promising results at EBMT 2025.

Functional respiratory tests may help predict outcomes in anti-CD19 CAR-T cell therapy, as shown in EBMT 2025 research.

Maintenance therapy significantly boosts outcomes for high-risk AML patients after transplantation, as highlighted at EBMT 2025.

New research has examined what drives clinicians to adopt intelligence-enabled diagnostic clinical decision support systems, and how to improve uptake.

Researchers introduce a new Genetic Progression Score (GPS) that enhances prediction of autoimmune disease progression by integrating biobank and case-control genetic data.